From the application of new products to the research and development of new treatments, regulatory affairs play a critical role in the pharmaceutical industry. It plays a variety of roles in the production of pharmacological products. In the pharmaceutical sector, regulatory affairs are similar to vehicle inspectors in the automobile industry. To put it another way, regulatory affairs exist to safeguard public health by assessing the processes of drug research, production, and promotion of pharmaceutical products. Regulatory affairs in the pharmaceutical sector encompasses a wide range of responsibilities. One of these responsibilities is to keep up with changes in pharmaceutical medication research, manufacturing, and marketing legislation.
A legally enforceable right to exclude others from applying the information generated or to determine the terms on which it can be used is known as intellectual property. IP rights are legal and institutional frameworks for protecting mental creations such as inventions, works of art and literature, and designs. They also use marks on products to distinguish them from comparable products marketed by competitors.
Title : Extracellular vesicles as delivery vehicles of therapeutic compounds
Stefania Raimondo, University of Palermo, Italy
Title : EU GMP annex1 barrier system and PIC/s annex 2A on cell and gene therapy
Richard Denk, SKAN AG, Switzerland
Title : Role of nanoformulations in treating Cystic Fibrosis
Bhupendra Gopalbhai Prajapati, Shree S.K.Patel College of Pharmaceutical Education and Research, India
Title : Dual GIP/GLP-1 receptor stimulation in treatment of type 2 diabetes mellitus – The ground-breaking 'twincretin' approach
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Pathology and patient safety: The vital role of electronic medical record and pathology informatics in error reduction and precision medicine
Consolato M Sergi, University of Ottawa, Canada
Title : Pro and con to dermpharm and tox assays- 2023
Howard I Maibach, University of California, United States
Title : mRNA-based systemically delivered directed gene therapy using nanomaterials
A C Matin, Stanford University, United States
Title : Colon-specific scallop hydrolysates/Κ-carrageenan hydrogel loaded with curcumin alleviates dss-induced colitis through modulation of inflammatory cytokines and gut microbiota
Hai Tao Wu, Dalian Polytechnic University, China
Title : Mucoadhesive electrospun fibrous systems for the fast and sustained delivery of drugs
Luis Jesus Villarreal Gomez, Autonomous University of Baja California, Mexico
Title : General and local anaesthetic agents: An analysis of their safety data
Francesca Gargano, Campus Bio-Medico University of Rome, Italy